Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mallolas

Showing results (41-50 of 137) with videos related to

Pageof 14
Sort By:
Medicina Clinica|January 6, 2001
[Influence of highly active antiretroviral therapy on the evolution of AIDS-associated Kaposi's sarcoma]Mercè Alsina M, F Bulla, C Conill, et al.
The British Journal of Dermatology|April 1, 1980
Acute and chronic graft-vs-host reaction in skin: report of two casesJ M Mascaro, C Rozman, J Palou, et al.
Journal of the Neurological Sciences|September 10, 1997
Skeletal muscle studies in patients with HIV-related wasting syndromeO Miró, E Pedrol, M Cebrián, et al.
Molecular and Cellular Probes|May 9, 2000
Rare variants in the promoter of the fragile X syndrome gene (FMR1)M Milà, S Castellví-Bel, A Sánchez, et al.
Medicina Clinica|January 18, 1992
[Study of neurological and cognitive changes in patients in stage III and initial phases of stage IV of infection by human immunodeficiency virus type 1]J Abós, F Graus, G Marqués, et al.
AIDS (London, England)|April 1, 1991
Intracranial tuberculomas in patients with AIDSJ Abós, F Graus, J M Miró, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|March 1, 1994
[Therapeutic alternatives for cases of cerebral toxoplasmosis in patients with AIDS: clarithromycin and atovaquone]A Guelar, J M Miró, J Mallolas, et al.
AIDS (London, England)|August 2, 2003
Comparison of metabolic abnormalities 48 weeks after switching from highly active antiretroviral therapy containing a non-nucleoside reverse transcriptase inhibitor to Trizivir versus continued highly active antiretroviral therapyC Katlama, B Gazzard, J Mallolas, et al.
European Journal of Human Genetics : EJHG|July 26, 2000
Loss of heterozygosity in renal and hepatic epithelial cystic cells from ADPKD1 patientsC Badenas, R Torra, L Pérez-Oller, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 30, 1998
High incidence of herpes zoster in patients with AIDS soon after therapy with protease inhibitorsE Martínez, J Gatell, Y Morán, et al.
Pageof 14

Showing results (41-50 of 137) with videos related to

Sort By:
Pageof 14
Medicina Clinica|January 6, 2001
[Influence of highly active antiretroviral therapy on the evolution of AIDS-associated Kaposi's sarcoma]Mercè Alsina M, F Bulla, C Conill, et al.
The British Journal of Dermatology|April 1, 1980
Acute and chronic graft-vs-host reaction in skin: report of two casesJ M Mascaro, C Rozman, J Palou, et al.
Journal of the Neurological Sciences|September 10, 1997
Skeletal muscle studies in patients with HIV-related wasting syndromeO Miró, E Pedrol, M Cebrián, et al.
Molecular and Cellular Probes|May 9, 2000
Rare variants in the promoter of the fragile X syndrome gene (FMR1)M Milà, S Castellví-Bel, A Sánchez, et al.
Medicina Clinica|January 18, 1992
[Study of neurological and cognitive changes in patients in stage III and initial phases of stage IV of infection by human immunodeficiency virus type 1]J Abós, F Graus, G Marqués, et al.
AIDS (London, England)|April 1, 1991
Intracranial tuberculomas in patients with AIDSJ Abós, F Graus, J M Miró, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|March 1, 1994
[Therapeutic alternatives for cases of cerebral toxoplasmosis in patients with AIDS: clarithromycin and atovaquone]A Guelar, J M Miró, J Mallolas, et al.
AIDS (London, England)|August 2, 2003
Comparison of metabolic abnormalities 48 weeks after switching from highly active antiretroviral therapy containing a non-nucleoside reverse transcriptase inhibitor to Trizivir versus continued highly active antiretroviral therapyC Katlama, B Gazzard, J Mallolas, et al.
European Journal of Human Genetics : EJHG|July 26, 2000
Loss of heterozygosity in renal and hepatic epithelial cystic cells from ADPKD1 patientsC Badenas, R Torra, L Pérez-Oller, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 30, 1998
High incidence of herpes zoster in patients with AIDS soon after therapy with protease inhibitorsE Martínez, J Gatell, Y Morán, et al.
Pageof 14